This topic contains a solution. Click here to go to the answer

Author Question: When inductors are connected in parallel, their total inductance acts like: A) resistance ... (Read 83 times)

Mr3Hunna

  • Hero Member
  • *****
  • Posts: 536
When inductors are connected in parallel, their total inductance acts like:
 
  A) resistance connected in series-parallel. B) resistance connected in series.
  C) resistance connected in parallel. D) all of these.

Question 2

Signals that vary continuously are called
 
  A) digital signals B) analog signals C) active circuits D) oscillators



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Rilsmarie951

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

C

Answer to Question 2

B




Mr3Hunna

  • Member
  • Posts: 536
Reply 2 on: Jul 28, 2018
Thanks for the timely response, appreciate it


frankwu0507

  • Member
  • Posts: 322
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library